CL2019000607A1 - Composición para aplicación tópica con actividad antifúngica. - Google Patents

Composición para aplicación tópica con actividad antifúngica.

Info

Publication number
CL2019000607A1
CL2019000607A1 CL2019000607A CL2019000607A CL2019000607A1 CL 2019000607 A1 CL2019000607 A1 CL 2019000607A1 CL 2019000607 A CL2019000607 A CL 2019000607A CL 2019000607 A CL2019000607 A CL 2019000607A CL 2019000607 A1 CL2019000607 A1 CL 2019000607A1
Authority
CL
Chile
Prior art keywords
composition
vitamin
ester
weight
essential oil
Prior art date
Application number
CL2019000607A
Other languages
English (en)
Inventor
Giorgio Panin
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Publication of CL2019000607A1 publication Critical patent/CL2019000607A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA COMPOSICIÓN PARA APLICACIÓN TÓPICA CON ACTIVIDAD ANTIFÚNGICA, QUE CONTIENE ACEITE ESENCIAL DE MELALEUCA ALTERNIFOLIA, ACEITE ESENCIAL DE ORÉGANO, ACEITE ESENCIAL DE LIMA Y UN ÉSTER DE VITAMINA E, QUE PUEDE SER, POR EJEMPLO, ACETATO DE VITAMINA E, NPROPIONATO O LINOLEATO, Y ES PREFERENTEMENTE ACETATO DE ALFA-TOCOFERILO; PREFERENTEMENTE, ESTOS ACEITES CONSTITUYEN AL MENOS 3% EN PESO DE LA COMPOSICIÓN Y CADA UNO DE ELLOS CONSTITUYE AL MENOS 1% EN PESO DE LA COMPOSICIÓN; PREFERENTEMENTE, LA COMPOSICIÓN CONTIENE DE 10% A 97% DE DICHO ÉSTER DE VITAMINA E Y PUEDE CONSISTIR DE LOS TRES ACEITES ESENCIALES MENCIONADOS EN LO ANTERIOR Y EL ÉSTER DE VITAMINA E; ALTERNATIVAMENTE, LA COMPOSICIÓN PUEDE ESTAR EN FORMA DE GEL HIDROFÓBICO, QUE CONTIENE DE 10 A 50% DEL ÉSTER DE LA VITAMINA E, DE 20 A 60% DE UNA MANTECA O CERA VEGETAL, DE 10 A 30% DE TRIGLICÉRIDOS DE ÁCIDO CAPRÍLICO Y CÁPRICO Y DEL 5 A 20% DE UN AGENTE GELIFICANTE PARA LÍPIDOS Y AL MENOS 3% DE LOS ACEITES ESENCIALES MENCIONADOS EN LO ANTERIOR, CADA UNO DE LOS CUALES CONSTITUYE AL MENOS EL 1% EN PESO DE LA COMPOSICIÓN.
CL2019000607A 2016-10-28 2019-03-11 Composición para aplicación tópica con actividad antifúngica. CL2019000607A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000109403A IT201600109403A1 (it) 2016-10-28 2016-10-28 Composizione per applicazione topica con attività antimicotica

Publications (1)

Publication Number Publication Date
CL2019000607A1 true CL2019000607A1 (es) 2019-07-26

Family

ID=58228397

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019000607A CL2019000607A1 (es) 2016-10-28 2019-03-11 Composición para aplicación tópica con actividad antifúngica.

Country Status (25)

Country Link
US (1) US10406193B2 (es)
EP (1) EP3493825B9 (es)
CN (1) CN109789179A (es)
AU (1) AU2017349996B2 (es)
BR (1) BR112019005016B1 (es)
CL (1) CL2019000607A1 (es)
CO (1) CO2019002445A2 (es)
CY (1) CY1123087T1 (es)
DK (1) DK3493825T3 (es)
EA (1) EA035264B1 (es)
ES (1) ES2803924T3 (es)
GE (2) GEP20207094B (es)
HR (1) HRP20200948T1 (es)
HU (1) HUE049596T2 (es)
IT (1) IT201600109403A1 (es)
LT (1) LT3493825T (es)
MA (1) MA45856B1 (es)
MX (1) MX2019002677A (es)
PL (1) PL3493825T3 (es)
PT (1) PT3493825T (es)
RS (1) RS60431B1 (es)
SA (1) SA519401296B1 (es)
SI (1) SI3493825T1 (es)
SM (1) SMT202000330T1 (es)
WO (1) WO2018077733A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL277230A (en) * 2020-09-09 2022-04-01 Yerushalmi Mantsur A therapeutic mixture with oregano oil for herpes infections
IT202000021367A1 (it) * 2020-09-09 2022-03-09 Sigla S R L Composizione a base di vitamina e per uso topico
IT202000021370A1 (it) * 2020-09-09 2022-03-09 Sigla S R L Composizione dermo-cosmetica per uso topico
IT202000021373A1 (it) * 2020-09-09 2022-03-09 Sigla S R L Composizione dermo-cosmetica per uso topico
CN111956566A (zh) * 2020-09-29 2020-11-20 广州弘莉生物科技有限公司 一种皮肤修护精华油及方法
US11710642B2 (en) 2021-03-23 2023-07-25 Changxin Memory Technologies, Inc. Semiconductor structure and manufacturing method thereof
CN113842481B (zh) * 2021-09-29 2023-03-17 华南农业大学 一种紫外杀菌增效剂莱姆精油及其应用
WO2026039635A1 (en) * 2024-08-14 2026-02-19 Foundling Pharma, Llc Improved compositions and methods for topical treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL186250B1 (pl) 1995-05-26 2003-12-31 Ropapharm Bv Zastosowanie tymolu i karwakrolu zawartych w olejkach eterycznych otrzymywanych z roślin, do użytkuw dziedzinie medycyny i weterynarii
IT1282778B1 (it) 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
FR2767062B1 (fr) * 1997-08-11 2000-03-17 Andre Pierre Morice Composition comprenant de la propolis
KR100285781B1 (ko) 1998-06-09 2001-05-02 최영신 항균및항진균작용이있는정유조성물
US6413555B1 (en) 2000-12-29 2002-07-02 All Nature's Solutions L.L.C. Composition and method of treating nail infections
US7258876B2 (en) * 2003-02-05 2007-08-21 Craig Bozzacco Topical composition for treating infectious conditions of skin and mucosa
US8753676B2 (en) * 2006-02-15 2014-06-17 Botanocap Ltd. Applications of microencapsulated essential oils
HRP20190493T1 (hr) * 2014-03-24 2019-05-03 Bio.Lo.Ga. S.R.L. Formulacija za osobnu higijenu
CN104146957A (zh) * 2014-07-24 2014-11-19 西安力邦肇新生物科技有限公司 亚微乳抗真菌药物喷雾剂制剂
CA2961298A1 (en) * 2014-09-29 2016-04-07 Botanocap Ltd. Non-woven fabric containing microencapsulated essential oils for preservation of crops

Also Published As

Publication number Publication date
CY1123087T1 (el) 2021-10-29
HUE049596T2 (hu) 2020-09-28
SA519401296B1 (ar) 2021-12-23
US20190224263A1 (en) 2019-07-25
MA45856B1 (fr) 2020-06-30
WO2018077733A1 (en) 2018-05-03
AU2017349996B2 (en) 2023-05-11
RS60431B1 (sr) 2020-07-31
ES2803924T3 (es) 2021-02-01
BR112019005016A8 (pt) 2022-07-05
EP3493825A1 (en) 2019-06-12
DK3493825T3 (da) 2020-06-22
LT3493825T (lt) 2020-07-27
SI3493825T1 (sl) 2020-09-30
GEAP201915008A (en) 2019-12-25
EA201990337A1 (ru) 2019-07-31
IT201600109403A1 (it) 2018-04-28
CO2019002445A2 (es) 2019-05-31
EP3493825B9 (en) 2020-08-19
MX2019002677A (es) 2019-09-26
PL3493825T3 (pl) 2020-09-21
BR112019005016B1 (pt) 2023-02-28
US10406193B2 (en) 2019-09-10
SMT202000330T1 (it) 2020-07-08
GEP20207094B (en) 2020-04-10
EA035264B1 (ru) 2020-05-21
HRP20200948T1 (hr) 2020-12-11
CA3033798A1 (en) 2018-05-03
PT3493825T (pt) 2020-06-16
AU2017349996A1 (en) 2019-03-07
EP3493825B1 (en) 2020-04-01
CN109789179A (zh) 2019-05-21
BR112019005016A2 (pt) 2019-06-04

Similar Documents

Publication Publication Date Title
CL2019000607A1 (es) Composición para aplicación tópica con actividad antifúngica.
MX2017003456A (es) Composiciones no grasas para el cuidado personal.
MX2020006964A (es) Composicion farmaceutica que comprende un cannabinoide.
MX2020006957A (es) Composicion de liberacion modificada que comprende un cannabinoide.
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
BR112019024641A2 (pt) Composições de óleo contendo éster alquílico intensificado e métodos de fabricação e utilização das mesmas
MX2016006094A (es) Eliminacion de componentes de propanol indeseables.
PE20141998A1 (es) Composiciones topicas que comprenden fipronilo y permetrina y sus metodos de uso
MX2015017457A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion.
MX2016014509A (es) Formulacion de vitamina soluble en grasa.
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
MX2015011255A (es) Composicion a base de flavonoides para uso farmaceutico, nutricional o cosmetico que tiene accion antioxidante potenciada.
PE20200925A1 (es) Composicion solida que comprende microparticulas que comprenden un componente oleoso y un componente lipidico
DOP2016000007A (es) Pirazolpiridinas sustituidas
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
BR112016021994B8 (pt) Formulação para a higiene pessoal
PL403509A1 (pl) Olejek eteryczny i aloes do stosowania w leczeniu i profilaktyce stanów zapalnych wywołanych przez nużeńce, zwłaszcza zapalenia brzegów powiek, kompozycja farmaceutyczna zawierająca olejek eteryczny i/lub aloes oraz zastosowanie olejku eterycznego i aloesu oraz ich kompozycja do wytwarzania preparatu do stosowania w leczeniu i profilaktyce wymienionych stanów zapalnych
AR107195A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales
BR112017012360A2 (pt) combinação de derivado de ácido piridina dicarboxílico/antioxidante particular
MX2017003100A (es) Composiciones terapeuticas y nutricionales para trastornos gastrointestinales funcionales.
PE20090249A1 (es) Composicion farmaceutica para el tratamiento de endometriosis
BR112014026879A2 (pt) formulação oral, e, substrato
CL2018000753A1 (es) Gel hidrófobo basado en vitamina e libre de productos de silicona para aplicación tópica
BR112015032594A2 (pt) cápsulas de camada de barreira
WO2015104298A3 (de) Polyphenol-konjugate